Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
To learn about the effectiveness of taking the antipsychotic medication olanzapine to help lower opioid craving.
Full description
Primary Objective To determine the effect of olanzapine on opioid craving among patients receiving opioids for cancer pain (Opioid Craving Scale; Opioid Craving Visual Analogue Scale, change from baseline)
Secondary Objective To determine the effect of olanzapine on opioid misuse among patients receiving opioids for cancer pain (Current Opioid Misuse Measure, change from baseline)
Exploratory Objective
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
87 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Joseph Arthur, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal